Pegylated interferons for the treatment of chronic hepatitis B.

Abstract

Five drugs are approved for the treatment of chronic hepatitis B: conventional interferon (IFN) alfa, lamivudine, adefovir dipivoxil, pegylated interferon (peginterferon) alfa-2a and entecavir. Conventional IFN monotherapy has a narrow range of efficacy, should be administered subcutaneously and is commonly associated with adverse effects. Lamivudine is… (More)

Topics

Cite this paper

@article{Liu2006PegylatedIF, title={Pegylated interferons for the treatment of chronic hepatitis B.}, author={Chun-Jen Liu and Jia-Horng Kao}, journal={Recent patents on anti-infective drug discovery}, year={2006}, volume={1 1}, pages={85-94} }